A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results, ...
Feb 23, 2024
0
29
More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and nearly 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all ...
Feb 7, 2024
0
0
Radiation is a targeted form of cancer treatment used for up to half of all patients with cancer. Most radiation treatments are delivered using focused X-rays. Because X-rays travel through tissues, this can lead to extra ...
Feb 7, 2024
0
0
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer.
Feb 1, 2024
0
41
Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoids or delays treatment like surgery or radiation ...
Jan 22, 2024
0
0
Scientists at Nottingham Trent University wanted to investigate the anti-cancer properties of carnosine against cells derived from both primary and metastatic prostate cancer—where the cancer began and where it had spread ...
Jan 5, 2024
0
38
A new review paper titled "Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review" has been published in Oncotarget.
Dec 11, 2023
0
0
When Joanina Gicobi began her Ph.D. degree five years ago at Mayo Clinic Graduate School of Biomedical Sciences, she was interested in thinking creatively about ways to improve cancer treatment. In particular, she was curious ...
Dec 4, 2023
0
97
In the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according to a study published online Nov. 9 in ...
Nov 15, 2023
0
0
Research led by the Dana Farber Cancer Institute, Massachusetts, performed a secondary analysis of the Dana-Farber Cancer Institute 05-043 trial. In the paper, "Risk of Short-Term Prostate-Specific Antigen Recurrence and ...
